Lung Diseases Cies Search Engine [selected websites]

Blog Archive

Nov 19, 2007

Gilead and LG Life Sciences, Global License Agreement to Advance Novel Drug Candidates for Treatment of Fibrotic Diseases

Nov. 6, 2007- ...Caspases are cellular proteases involved in processes such as apoptosis (cell death) and inflammation. By inhibiting various caspases, it may be possible to slow or stop the progression of fibrosis in the liver for patients with chronic viral hepatitis and non-alcoholic steatohepatitis (NASH), as well as potentially in other fibrotic diseases such as idiopathic pulmonary fibrosis (IPF)... Gilead's Press Release - LG Life Sciences' Press Release -